DOI:
10.1055/s-00000129
Kardiologie up2date
LinksClose Window
References
Eng CM, Banikazemi M, Gordon RE. et al.
A phase 1/2 clinical trial of enzyme replacement in Fabry disease: pharmacokinetic, substrate clearance, and safety studies.
Am J Hum Genet 2001; 68: 711-722
We do not assume any responsibility for the contents of the web pages of other providers.